Welcome

Please send your feedback and suggestions for developing this infant website to; Su Golder at; spg3 doesnotexist@cochrane.org york.ac.uk

We would like to thank the Drug Safety Research Unit (DSRU), Saad Shakir, Andy Boshier and Andrea Clarke for hosting the precursor to this website.

The Cochrane Adverse Effects Methods Group (AEMG) was formally registered with The Cochrane Collaboration on the 14th June 2007. The Group aims to develop the methods for producing high quality systematic reviews and to advise the Cochrane Collaboration on how the validity and precision of systematic reviews can be improved.

The main purposes of the group are;
• to raise awareness of the adverse effects of interventions, and to promote the inclusion of adverse effects data in Cochrane reviews;
• to provide educational help to reviewers and users of reviews to spread and deepen understanding of the principles involved in assessing adverse effects;
• to provide methodological guidance on specific aspects of evaluating adverse effects;
• to identify areas of methodological uncertainty, and to develop a toolbox for the assessment of adverse effects.